Skip to main content

Congenital Heart Disease clinical trials at UCSF
1 in progress, 1 open to new patients

  • Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients

    open to eligible people ages 4–60

    The study involves documenting the effects of inhaled nitric oxide upon ventricular-arterial coupling in patients with congenital heart disease and passive pulmonary blood flow. Consenting patients undergoing a clinically-indicated cardiac catheterization will be given inhaled nitric oxide for 10 minutes while intraventricular pressure-volume analysis will be make via conduction catheters.

    San Francisco, California